Search clinical trials for: Relapsed/ Refractory Multiple Myeloma
Total 21493 results
-
Nantes University HospitalWithdrawnCD22+ Relapsed/Refractory B-ALLFrance
-
Stemline Therapeutics, Inc.TerminatedMultiple MyelomaUnited States
-
Zhujiang HospitalThe Third Affiliated Hospital of Southern Medical University; Sun Yat-Sen Memorial... and other collaboratorsTerminatedRelapsed/Refractory Multiple Myeloma(MM)China
-
AbbVieActive, not recruitingChronic Lymphocytic LeukemiaGreece
-
The Sixth Affiliated Hospital of Wenzhou Medical...Zhejiang Qixin BiotechUnknown
-
Fondazione Italiana Linfomi - ETSActive, not recruitingDiffuse Large B-cell LymphomaItaly
-
GlaxoSmithKlineCompletedNon-Small-Cell Lung CancerUnited States, Belgium, United Kingdom
-
University Hospital, BordeauxNot yet recruitingStudy of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed Glioblastoma (GBrecurr)Relapsed Cancer | Glioblastoma IDH (Isocitrate Dehydrogenase) WildtypeFrance
-
Wake Forest University Health SciencesBristol-Myers Squibb; Atrium Health Levine Cancer InstituteActive, not recruitingMultiple MyelomaUnited States
-
ImmunoGen, Inc.Completed
-
Ciusss de L'Est de l'Île de MontréalUnknownRelapsed Multiple Myeloma | Relapsed Non Hodgkin Lymphoma | Hematologic Cancer | Relapsed Adult AML | Relapse Leukemia | Relapsed Adult ALL | Relapsed CLL | Relapsed Hodgkin's Lymphoma | Relapsed Myelodysplastic SyndromesCanada
-
Thomas Martin, MDSanofi; AmgenActive, not recruitingMultiple MyelomaUnited States, Canada
-
Regeneron PharmaceuticalsAvailable
-
Peter MacCallum Cancer Centre, AustraliaMelbourne HealthCompleted
-
Bristol-Myers SquibbCompleted
-
Massachusetts General HospitalSanofi; GlaxoSmithKlineNot yet recruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapsed CancerUnited States
-
Regeneron PharmaceuticalsRecruitingMultiple MyelomaBelgium, United States, Japan, Korea, Republic of, Germany, Spain, United Kingdom
-
PfizerIn Expanded Access, treating physicians are the SponsorsAvailable
-
Massachusetts General HospitalMultiple Myeloma Research ConsortiumActive, not recruitingMultiple MyelomaUnited States
-
CelgeneTerminatedMultiple MyelomaUnited States, Canada, Spain, Italy, Denmark, United Kingdom, Belgium, Sweden, Germany
-
Dana-Farber Cancer InstituteTerminatedMultiple Myeloma | ThrombocytopeniaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteKaryopharm Therapeutics IncCompletedMultiple MyelomaUnited States
-
PETHEMA FoundationBristol-Myers Squibb; Celgene; Adknoma Health Research, S.L.TerminatedMultiple MyelomaSpain
-
Korean Multiple Myeloma Working PartyCelgene CorporationUnknownMultiple MyelomaKorea, Republic of
-
Millennium Pharmaceuticals, Inc.No longer availableMultiple MyelomaUnited States
-
AbbVieGenentech, Inc; Onyx Therapeutics, Inc.Active, not recruitingMultiple MyelomaUnited States, Australia, Hungary, Puerto Rico, Spain
-
Bayside HealthTerminated
-
Case Comprehensive Cancer CenterFlorida International University; Community Foundation of BrowardRecruitingRelapsed Cancer | Refractory CancerUnited States
-
Amsterdam UMC, location VUmcOdense University Hospital; Helsinki University Central Hospital; Aarhus University... and other collaboratorsRecruitingCML, RelapsedDenmark, Norway, Sweden, Netherlands, Finland, France, Germany
-
Stanford UniversityAmgen; Pediatric Oncology Experimental Therapeutics Investigators' ConsortiumCompletedRefractory Leukemia | Refractory Solid Tumors | Relapsed Solid Tumors | Relapsed LeukemiaUnited States, Canada
-
Ciceri FabioAssociazione Italiana per la Ricerca sul Cancro; Gruppo Italiano Trapianto...Recruiting
-
pharmaand GmbHCompletedMultiple MyelomaCanada, Spain, United States, Czechia, Turkey, France, Sweden, Korea, Republic of, Thailand, Belgium, Greece, Germany, Hungary, Russian Federation, Italy, Poland, Australia, Lebanon, Portugal, Norway, Brazil, Netherlands
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
Technische Universität DresdenAbbVieActive, not recruitingRelapsed Adult AML | Refractory AMLGermany
-
Xinxiang medical universityRecruiting
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Acute Myeloid Leukemia | Relapsed or Refractory Non-Hodgkin Lymphoma | Relapsed or Refractory Chronic Lymphocytic LeukemiaUnited Kingdom, Spain, France, Australia
-
Infinity Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
Stichting European Myeloma NetworkFondazione EMN Italy OnlusCompletedMultiple MyelomaGermany, Italy
-
European Myeloma NetworkFondazione EMN Italy OnlusCompleted
-
University of LeedsMillennium Pharmaceuticals, Inc.; Myeloma UKUnknown
-
Gilead SciencesTerminated
-
Robert Redner, MDCephalonCompleted
-
Fondazione EMN Italy OnlusCompleted
-
University Hospital FreiburgMerck Sharp & Dohme LLC; Janssen-Cilag Ltd.Completed
-
Haisco Pharmaceutical Group Co., Ltd.RecruitingRelapsed/Refractory B-Cell MalignanciesChina, Australia
-
Minghui Pharmaceutical (Shanghai) LTDRecruitingRelapsed/Refractory B-cell MalignanciesChina
-
Gilead SciencesCompletedRelapsed/Refractory B-cell MalignanciesFrance, United Kingdom
-
Newave Pharmaceutical IncRecruitingAcute Myeloid Leukemia | Multiple Myeloma | Myelofibrosis | Chronic Lymphocytic Leukemia | Non Hodgkin Lymphoma | Acute Lymphocytic Leukemia | Myelodysplastic/Myeloproliferative Neoplasm | Small Lymphocytic Lymphoma | Chronic Myelomonocytic Leukemia-2 | Richter Transformation | T-cell-prolymphocytic Leukemia and other conditionsUnited States
-
Oncopeptides ABPrecision For MedicineCompletedMultiple MyelomaSpain, United States, France, Italy
-
Tulane University School of MedicineKaryopharm Therapeutics IncWithdrawnRefractory Multiple Myeloma | Relapsed Multiple Myeloma